about
Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogensMolecular imaging of oncolytic viral therapyThe sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapiesGenetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approachImaging technologies for monitoring the safety, efficacy and mechanisms of action of cell-based regenerative medicine therapies in models of kidney disease.Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.Comparison of 18F PET and 99mTc SPECT imaging in phantoms and in tumored micePatient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes.Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.A practical, automated synthesis of meta-[(18)F]fluorobenzylguanidine for clinical use.A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging.Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.PET molecular imaging in stem cell therapy for neurological diseases.Noninvasive cell-tracking methods.Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications.124 Iodine: a longer-life positron emitter isotope-new opportunities in molecular imaging.The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.Fluorescence-guided development of a tricistronic vector encoding bimodal optical and nuclear genetic reporters for in vivo cellular imaging.Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.In vitro and in vivo studies of adenovirus-mediated human norepinephrine transporter gene transduction to hepatocellular carcinoma.A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.Norepinephrine Transporter as a Target for Imaging and Therapy.Single-Cell Imaging Using Radioluminescence Microscopy Reveals Unexpected Binding Target for [18F]HFB.Radiolabeling strategies for radionuclide imaging of stem cells.The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses.[Simultaneous whole-body PET-MRI in pediatric oncology : More than just reducing radiation?].
P2860
Q26852810-57EE5C0A-B2BE-4F10-A16E-7691B6FF9A33Q26999406-719429FB-D3F0-4D27-B411-07F76C5A0F81Q27023157-BA3C736F-BEE8-422E-A703-31C71848E1A0Q28078109-B0C633D3-941B-4DBA-9D8B-27DD86EEACA6Q30370543-F5E70AB1-8BE8-4915-BA7C-DAE89AFFBBB2Q33834340-59080513-2E6E-4CE6-B710-27D6ED8F57CFQ33887850-564BE4F3-9B81-4B32-8C7F-B7DBEE427416Q34117552-0A669521-F4E6-4CCF-AFB7-9C13F4D7FB39Q34169691-82A44614-E7D7-42C2-AAA8-5F3B4C9274F3Q35109012-8D0524FA-1F63-446F-A7A4-2780DF45BE57Q35609644-D5FFB5B2-DB75-40D9-AC02-63F7A7AE59FAQ35880086-00381275-1092-4074-AB9C-C6A2028F1FACQ36013113-4D8E1F87-7020-46A1-A67F-B26999F00A02Q36296809-9A1EB11B-9630-4BE9-91FC-C458799F8E81Q37126192-2DE3FD2B-FA59-4A81-B3C9-6997A10589EBQ37864159-724B53C1-E479-4922-8E5A-A0FAD4B02364Q37893537-8C7C502B-A512-48E2-BC49-B65439FADEFBQ37938642-869BDF22-5497-4FA1-A3ED-B44EE524C922Q38003153-73A77024-3948-47BF-AF26-639E8B4FEDD5Q38217491-4D3C9E5B-78C7-4FC1-A452-03961355F3A3Q38217493-461040A4-9F7A-4859-AEEF-2A3601B91380Q38673968-14CB9B09-D612-4441-B81F-E4B7E55CF6A3Q38889816-C00829A2-7274-4F51-BBE4-99D09C2D3AB6Q39068651-EB914CB4-9FB8-48FF-A290-68E2D133F7A8Q39632795-C098B28A-07BE-4815-88E6-FA2853530ADDQ39660810-EDEA0E55-CBE4-4966-917B-74D47FD32D99Q39991887-46E5CB53-1F8A-4839-9707-0C301DFD39F3Q40327489-F414DC92-9BA6-437A-9455-EAE354C82DE5Q47867820-AF021CF9-A4EC-4292-8AC3-AACB770972F7Q48295408-A10FBE58-764B-41D9-8141-192EEAEF8DA7Q48692331-BFD316EB-73E7-410B-815D-9CA282233030Q52594999-A7F10EB2-67B8-4A6E-92E2-C66AA3CF29A4Q52982322-A09D6D3C-5242-428F-9E4F-9781172E9F46
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Imaging hNET reporter gene expression with 124I-MIBG.
@ast
Imaging hNET reporter gene expression with 124I-MIBG.
@en
Imaging hNET reporter gene expression with 124I-MIBG.
@nl
type
label
Imaging hNET reporter gene expression with 124I-MIBG.
@ast
Imaging hNET reporter gene expression with 124I-MIBG.
@en
Imaging hNET reporter gene expression with 124I-MIBG.
@nl
prefLabel
Imaging hNET reporter gene expression with 124I-MIBG.
@ast
Imaging hNET reporter gene expression with 124I-MIBG.
@en
Imaging hNET reporter gene expression with 124I-MIBG.
@nl
P2093
P1476
Imaging hNET reporter gene expression with 124I-MIBG
@en
P2093
Ekaterina Dyomina
Eva Burnazi
Ludmila Ageyeva
Maxim A Moroz
Michael Doubrovin
Pat Zanzonico
Ronald D Finn
Ronald G Blasberg
Tatiana Beresten
P304
P356
10.2967/JNUMED.106.037812
P407
P577
2007-05-01T00:00:00Z